These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29079176)

  • 1. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
    Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S
    Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
    Li WT; Jeng YM; Yang CY
    Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
    Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
    Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
    Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P
    Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.
    Werling RW; Yaziji H; Bacchi CE; Gown AM
    Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people.
    Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS
    APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of MUC1, MUC2 and CK17 expression patterns for diagnosis of pancreatobiliary arcinoma.
    Yang HS; Tamayo R; Almonte M; Horten B; DaSilva M; Gangi M; Vazquez E; Joseph D; Okamoto P; Scholl T
    Biotech Histochem; 2012 Feb; 87(2):126-32. PubMed ID: 21438791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
    Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
    Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
    Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
    Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepPar-1 and Arginase-1 Immunohistochemistry in Adenocarcinoma of the Small Intestine and Ampullary Region.
    Lagana S; Hsiao S; Bao F; Sepulveda A; Moreira R; Lefkowitch J; Remotti H
    Arch Pathol Lab Med; 2015 Jun; 139(6):791-5. PubMed ID: 26030248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
    Fernández Moro C; Fernandez-Woodbridge A; Alistair D'souza M; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Björnstedt M; Löhr JM; Isaksson B; Verbeke C; Bozóky B
    PLoS One; 2016; 11(11):e0166067. PubMed ID: 27829047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR; Jayachandran P; Chang DT; Pai R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins.
    De Michele S; Remotti HE; Del Portillo A; Lagana SM; Szabolcs M; Saqi A
    Am J Clin Pathol; 2021 Jan; 155(1):124-132. PubMed ID: 32914850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
    Moy AP; Arora K; Deshpande V
    Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
    Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.